Free Trial

The Rally in Walgreen’s Boots Alliance May be Short Lived

→ 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad)
The Rally in Walgreen’s Boots Alliance May be Short Lived

Key Points

  • A double beat on the company’s earnings report sent WBA stock up more than 6%. 
  • The bounce appears to be more of a relief rally based on the company’s guidance. 
  • The underlying fundamentals still show sluggish growth. 
  • Without more growth WBA stock may be reaching value trap levels.  
  • 5 stocks we like better than Walgreens Boots Alliance

Shares of Walgreens Boots Alliance (NYSE: WBA) are up more than 6% after the company posted a double beat in its fourth quarter earnings report. The company wrapped up its fiscal year with earnings per share (EPS) of 80 cents on revenue of $32.45 billion. That beat analysts’ expectations for an EPS of 71 cents and revenue of $32.15 billion.  

This made it eight straight quarters that Walgreen’s has surpassed analysts’ estimates. And yet, WBA stock still seems to be flashing a caution signal. And that may mean this current bump in the stock price will be short-lived.  

This Time Good News Was Good News 

For weeks, the markets have been selling on good news and climbing on bad news. However, the Walgreen’s report is giving investors something to believe in. Specifically, the company issued full-year earnings guidance in the range of $4.45 to $4.65 per share. Analysts are forecasting full-year EPS of $4.53.  

That means Walgreen’s number is, perhaps, the first sign that the earnings recession being widely forecasted will not be as bad as feared. Or, at the very least, may hold off until after the holiday season. In fact, that may be one reason the entire market seemed to get a lift for the day. 

Still, WBA stock is down 6% for the month and 28% for the last 12 months. That means it’s posting a worse loss than the S&P 500 and the Dow Jones Industrial Average (DJIA). And therein lies the concern for investors.  

Growth Remains a Challenge 

Beating estimates is encouraging, but it doesn’t mean that Walgreen’s is undervalued. The problem for Walgreen’s is the underlying trends. 

For example, revenue was down sequentially in every quarter this year. And each of those quarters was down from the same quarter in the prior year.  

Ok, you say but 2021 isn’t a fair comparison. But if you back it up to 2020, the revenue is still lower. In fact, investors would have to go back to the end of 2017 to start finding comparable revenue numbers. 

And the picture for earnings is even worse. Except for the quarter that aligned with the beginning of the Covid-19 pandemic, the company hasn’t posted an earnings number of below $1 since 2015.  


Both the revenue and earnings numbers are consequences of the company’s operating margins which are down over the last 10 years. And the outlook for both in the next five years is essentially flat. 

All is not bad news, however. Walgreen’s is still generating a healthy amount of free cash flow. But even there the trend is going in the wrong direction. As a percentage of its net income, it’s down almost 15% in the last three years.  

Not a Value Trap...Yet 

With a dividend yield of just under 6% (5.88%) as of this writing, Walgreens’ stock is sure to catch the attention of many income-oriented investors. After all, the company is a dividend aristocrat with 46 consecutive years of dividend increases.  

And with a 12% free cash flow yield, the dividend looks safe.  

Plus, the company is trading at an almost ridiculously low price-to-earnings (P/E) ratio of 5.4x, it’s not wrong to believe there’s value in owning WBA stock. But without evidence that the company can find a way to change around the growth story, it’s becoming hard to do anything other than to put the stock on a watch list. 

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Walgreens Boots Alliance (WBA)
4.6713 of 5 stars
$16.03+0.5%6.24%-2.29Reduce$24.36
Compare These Stocks  Add These Stocks to My Watchlist 

Chris Markoch

About Chris Markoch

  • CTMarkoch@msn.com

Editor & Contributing Author

Retirement, Individual Investing

Experience

Chris Markoch has been an editor & contributing writer for MarketBeat since 2018.

Areas of Expertise

Value investing, retirement stocks, dividend stocks

Education

Bachelor of Arts, The University of Akron

Past Experience

InvestorPlace


Featured Articles and Offers

Search Headlines: